文献
J-GLOBAL ID:201702274430345057
整理番号:17A1170651
D-アミノ酸ペプチド治療etelcalcetideの臨床的免疫原性:方法の開発挑戦と抗薬物抗体臨床的影響評価【Powered by NICT】
Clinical immunogenicity of the d-amino acid peptide therapeutic etelcalcetide: Method development challenges and anti-drug antibody clinical impact assessments
著者 (8件):
Kroenke Mark A.
(Amgen Inc., Medical Sciences, Thousand Oaks, CA, United States)
,
Weeraratne Dohan K.
(Amgen Inc., Pharmacokinetics and Drug Metabolism, Thousand Oaks, CA, United States)
,
Deng Hongjie
(Amgen Inc., Global Biostatistical Sciences, Thousand Oaks, CA, United States)
,
Sloey Bethlyn
(Amgen Inc., Medical Sciences, Thousand Oaks, CA, United States)
,
Subramanian Raju
(Amgen Inc., Pharmacokinetics and Drug Metabolism, Thousand Oaks, CA, United States)
,
Wu Benjamin
(Amgen Inc., Medical Sciences, Thousand Oaks, CA, United States)
,
Serenko Michael
(Amgen Inc., Global Safety, Cambridge, MA, United States)
,
Hock M. Benjamin
(Amgen Inc., Medical Sciences, Thousand Oaks, CA, United States)
資料名:
Journal of Immunological Methods
(Journal of Immunological Methods)
巻:
445
ページ:
37-44
発行年:
2017年
JST資料番号:
E0816B
ISSN:
0022-1759
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)